BridgeMD
New treatment option for Depressive Symptom
Official title Digital Cognitive Behavioral Therapy for Chinese Adolescents With Depressive Symptoms（CADS-D )
ClinicalTrials.gov ID: NCT07163013
What this study is testing
- What it's testing
- CADS-D aimes to evaluate the effectiveness and feasibility of a newly DCBT program for Chinese adolescents with depressive symptoms.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 18
You may be able to join if
- Age 12 to 18 years;
- Scored 28 or higher on the children's depression rating scale-revised (CDRS-R);
- Have the ability to read and write in Chinese;
- Participant and at least one of their guardians provided written consent;
- Have access to mobile phone and internet.
You likely can't join if
- The researchers assessed that the adolescent's depressive symptoms were too severe to participate to CADS-D;
- Scored 5 or higher on item 13 (suicidal ideation) on CDRS-R;
- Participants who met diagnosis of other mental disorder except depression;
- Severe physical illnesses or other physical disabilities that prevented the use of DCBT;
- Within the past three months or currently undergoing any antidepressant treatment, including medication therapy, psychotherapy, and physical therapy;
- Unavailability to follow up months after intervention.
The study team makes the final eligibility decision.
Where it's taking place
- Chongqing, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chongqing, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.